ATE176782T1 - Heterocyclische verbindungen und pharmazeutische verwendung - Google Patents
Heterocyclische verbindungen und pharmazeutische verwendungInfo
- Publication number
- ATE176782T1 ATE176782T1 AT94303155T AT94303155T ATE176782T1 AT E176782 T1 ATE176782 T1 AT E176782T1 AT 94303155 T AT94303155 T AT 94303155T AT 94303155 T AT94303155 T AT 94303155T AT E176782 T1 ATE176782 T1 AT E176782T1
- Authority
- AT
- Austria
- Prior art keywords
- heterocyclic compounds
- pharmaceutical use
- compounds
- formula
- intermediates
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940127315 Potassium Channel Openers Drugs 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310069A GB9310069D0 (en) | 1993-05-17 | 1993-05-17 | Heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE176782T1 true ATE176782T1 (de) | 1999-03-15 |
Family
ID=10735574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94303155T ATE176782T1 (de) | 1993-05-17 | 1994-04-29 | Heterocyclische verbindungen und pharmazeutische verwendung |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5504089A (de) |
| EP (1) | EP0625511B1 (de) |
| JP (1) | JPH072793A (de) |
| AT (1) | ATE176782T1 (de) |
| CA (1) | CA2123637A1 (de) |
| DE (1) | DE69416540T2 (de) |
| GB (1) | GB9310069D0 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU731391B2 (en) * | 1996-08-19 | 2001-03-29 | Kissei Pharmaceutical Co. Ltd. | Drug for the prevention or treatment of pollakiuria and urinary incontinence |
| GB9804648D0 (en) | 1998-03-06 | 1998-04-29 | Zeneca Ltd | Chemical compounds |
| GB9805520D0 (en) | 1998-03-17 | 1998-05-13 | Zeneca Ltd | Chemical compounds |
| GB9811427D0 (en) | 1998-05-29 | 1998-07-22 | Zeneca Ltd | Chemical compounds |
| WO2000067754A1 (en) | 1999-05-12 | 2000-11-16 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| WO2001017942A1 (en) | 1999-09-04 | 2001-03-15 | Astrazeneca Ab | Amides as inhibitors for pyruvate dehydrogenase |
| BR0013694A (pt) | 1999-09-04 | 2002-05-21 | Astrazeneca Ab | Composto, processo para a preparação de um composto, composição farmacêutica, e, uso de um composto |
| JP4953456B2 (ja) * | 2004-09-30 | 2012-06-13 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 選択的アンドロゲン受容体モジュレーター（ｓａｒｍ）として有用な新規なベンゾイミダゾール誘導体 |
| PL1984343T3 (pl) | 2006-01-24 | 2013-08-30 | Janssen Pharmaceutica Nv | 2-podstawione benzimidazole jako selektywne modulatory receptora androgenowego (SARM) |
| US8853347B2 (en) | 2011-11-24 | 2014-10-07 | Samsung Electronics Co., Ltd. | Organic semiconductor compound, organic thin film including the organic semiconductor compound and electronic device including the organic thin film, and method of manufacturing the organic thin film |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3214429A (en) * | 1963-04-05 | 1965-10-26 | Hoffmann La Roche | Quinazolinones and process for preparing |
| US3666769A (en) * | 1969-10-09 | 1972-05-30 | Du Pont | Thermally stable 2-perfluoro-substituted benzothiazoles |
| GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
| GB9220570D0 (en) * | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
| IL105558A (en) * | 1992-05-18 | 1998-04-05 | Zeneca Ltd | Tertiary carbinols having potassium channel activity, process for their preparation and pharmaceutical compositions containing them |
-
1993
- 1993-05-17 GB GB939310069A patent/GB9310069D0/en active Pending
-
1994
- 1994-04-29 DE DE69416540T patent/DE69416540T2/de not_active Expired - Fee Related
- 1994-04-29 AT AT94303155T patent/ATE176782T1/de active
- 1994-04-29 EP EP94303155A patent/EP0625511B1/de not_active Expired - Lifetime
- 1994-05-13 US US08/242,521 patent/US5504089A/en not_active Expired - Lifetime
- 1994-05-16 CA CA002123637A patent/CA2123637A1/en not_active Abandoned
- 1994-05-17 JP JP6103067A patent/JPH072793A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US5504089A (en) | 1996-04-02 |
| DE69416540D1 (de) | 1999-03-25 |
| JPH072793A (ja) | 1995-01-06 |
| GB9310069D0 (en) | 1993-06-30 |
| CA2123637A1 (en) | 1994-11-18 |
| EP0625511B1 (de) | 1999-02-17 |
| DE69416540T2 (de) | 1999-09-23 |
| EP0625511A1 (de) | 1994-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0524781T3 (da) | Terapeutiske amider | |
| HU9600834D0 (en) | Quinazoline derivatives | |
| DE69531502D1 (de) | Monoamid, diamid, thiol enthaltende metall-chelatierende verbindungen | |
| DE69429591D1 (de) | Therapeutisch wirksame Verbindungen | |
| ATE248837T1 (de) | Chinuclidin-acrylamide | |
| PT1029853E (pt) | Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos | |
| NO996108L (no) | 9-oksinerytromycinderivater | |
| GB9318935D0 (en) | Heterocyclic derivatives | |
| AU697679B2 (en) | Treatment of tinnitis using neuroprotective agents | |
| GB9310095D0 (en) | Therapeutic compounds | |
| PT992509E (pt) | Novos derivados macrolidos | |
| ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
| DE69416540D1 (de) | Heterocyclische Verbindungen und pharmazeutische Verwendung | |
| ATE161006T1 (de) | Alkohole als kaliumchannelöffner und zur behandlung der harnincontinenz | |
| YU46302A (sh) | Supstituisani piroli | |
| ATE88176T1 (de) | 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung. | |
| DK0566288T3 (da) | Flavon-derivater |